PREDICT: model for prediction of survival in localized prostate cancer

被引：0
|
作者：
Linda G. W. Kerkmeijer
Evelyn M. Monninkhof
Inge M. van Oort
Henk G. van der Poel
Gert de Meerleer
Marco van Vulpen
机构：
[1] University Medical Center Utrecht,Department of Radiation Oncology
[2] University Medical Center Utrecht,Julius Center for Health Sciences and Primary Care
[3] Radboud University Medical Center,Department of Urology
[4] Netherlands Cancer Institute,Department of Urology, Antoni van Leeuwenhoek Hospital
[5] Ghent University Hospital,Department of Radiation Oncology
来源：
World Journal of Urology | 2016年 / 34卷
关键词：
Grade; Prediction; Prostate cancer; PSA; Survival; T-stage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：789 / 795
页数：6
相关论文
共 50 条
  • [21] The impact of comorbidity on survival among men with localized prostate cancer
    Lu-Yao, G. L.
    Moore, D.
    Shih, W.
    Lin, Y.
    Li, H.
    Albertsen, P. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [22] Impact of Comorbidity on Survival Among Men With Localized Prostate Cancer
    Albertsen, Peter C.
    Moore, Dirk F.
    Shih, Weichung
    Lin, Yong
    Li, Hui
    Lu-Yao, Grace L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) : 1335 - 1341
  • [23] Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer
    Kanai, Kunimitsu
    Nakashima, Jun
    Sugawara, Akitomo
    Shigematsu, Naoyuki
    Nagata, Hirohiko
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Kubo, Atsushi
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (06) : 502 - 506
  • [24] Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer
    Kunimitsu Kanai
    Jun Nakashima
    Akitomo Sugawara
    Naoyuki Shigematsu
    Hirohiko Nagata
    Eiji Kikuchi
    Akira Miyajima
    Ken Nakagawa
    Atsushi Kubo
    Mototsugu Oya
    International Journal of Clinical Oncology, 2009, 14 : 502 - 506
  • [25] Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
    Xie, Wanling
    Regan, Meredith M.
    Buyse, Marc
    Halabi, Susan
    Kantoff, Philip W.
    Sartor, Oliver
    Soule, Howard
    Clarke, Noel W.
    Collette, Laurence
    Dignam, James J.
    Fizazi, Karim
    Paruleker, Wendy R.
    Sandler, Howard M.
    Sydes, Matthew R.
    Tombal, Bertrand
    Williams, Scott G.
    Sweeney, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (27) : 3097 - 3104
  • [26] Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
    Mayes, Janice M.
    Mouraviev, Vladimir
    Sun, Leon
    Tsivian, Matvey
    Madden, John F.
    Polascik, Thomas J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (02) : 166 - 170
  • [27] Harnessing machine learning to predict prostate cancer survival: a review
    Bang, Sungun
    Ahn, Young Jin
    Koo, Kyo Chul
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [28] Prediction of extraprostatic cancer by serum [-2] pro prostate specific antigen in clinically localized prostate cancer
    Nakashima, Jun
    Yamazaki, Keiichi
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    Ohigashi, Takashi
    Murai, Masaru
    JOURNAL OF UROLOGY, 2007, 177 (04): : 380 - 381
  • [29] Disease-free survival in Latino men with localized prostate cancer
    不详
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 3 - 3
  • [30] Association of neutrophil count with overall survival in localized prostate cancer.
    Taussky, Daniel
    Bahig, Houda
    Delouya, Guila
    Bodson-Clermont, Paule
    Soulieres, Denis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345